{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:46:42Z","timestamp":1792702002415,"version":"4.5.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/med.0b013e32834041d4","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T01:44:46Z","timestamp":1294969486000},"page":"561-567","source":"Crossref","is-referenced-by-count":18,"title":["Disorders of phosphorus homeostasis"],"prefix":"10.1097","volume":"17","author":[{"given":"Richard","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20211004","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1681\/ASN.2009111104","article-title":"Common genetic variants associate with serum phosphorus concentration","volume":"21","author":"Kestenbaum","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R2-12-20211004","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2010.01.006","article-title":"Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets","volume":"86","author":"Lorenz-Depiereux","year":"2010","journal-title":"Am J Hum Genet"},{"key":"R3-12-20211004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajhg.2010.01.010","article-title":"Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene","volume":"86","author":"Levy-Litan","year":"2010","journal-title":"Am J Hum Genet"},{"key":"R4-12-20211004","doi-asserted-by":"crossref","first-page":"F671","DOI":"10.1152\/ajprenal.00156.2009","article-title":"Npt2a and Npt2c in mice play distinct and synergistic roles in inorganic phosphate metabolism and skeletal development","volume":"297","author":"Segawa","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R5-12-20211004","doi-asserted-by":"crossref","first-page":"F1341","DOI":"10.1152\/ajprenal.00375.2009","article-title":"Phosphaturic action of fibroblast growth factor 23 in Npt2 null mice","volume":"298","author":"Tomoe","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"R6-12-20211004","doi-asserted-by":"crossref","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R7-12-20211004","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.2008070783","article-title":"Initial FGF23-mediated signaling occurs in the distal convoluted tubule","volume":"20","author":"Farrow","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R8-12-20211004","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1096\/fj.08-123992","article-title":"Inactivation of Klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model","volume":"23","author":"Nakatani","year":"2009","journal-title":"FASEB"},{"key":"R9-12-20211004","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1096\/fj.08-114397","article-title":"In vivo genetic evidence for Klotho-dependent, fibroblast growth factor 23 (Fgf23)-mediated regulation of systemic phosphate homeostasis","volume":"23","author":"Nakatani","year":"2009","journal-title":"FASEB"},{"key":"R10-12-20211004","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1152\/ajpendo.90539.2008","article-title":"Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype","volume":"296","author":"Bai","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R11-12-20211004","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"R12-12-20211004","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse Klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"R13-12-20211004","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCGENETICS.108.847814","article-title":"In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin D levels","volume":"2","author":"Ohnishi","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"R14-12-20211004","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1096\/fj.09-152488","article-title":"Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging","volume":"24","author":"Ohnishi","year":"2010","journal-title":"FASEB J"},{"key":"R15-12-20211004","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ki.2009.24","article-title":"Reversal of mineral ion homeostasis and soft-tissue calcification of Klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase","volume":"75","author":"Ohnishi","year":"2009","journal-title":"Kidney Int"},{"key":"R16-12-20211004","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1074\/jbc.M109.030577","article-title":"Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and Klotho","volume":"285","author":"Xiao","year":"2009","journal-title":"J Biol Chem"},{"key":"R17-12-20211004","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/jbmr.65","article-title":"Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D(3) synthesis in leptin-deficient ob\/ob mice","volume":"25","author":"Tsuji","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R18-12-20211004","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1172\/JCI36479","article-title":"Endocrine functions of bone in mineral metabolism regulation","volume":"118","author":"Quarles","year":"2008","journal-title":"J Clin Invest"},{"key":"R19-12-20211004","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000325318","article-title":"Aspiration biopsy cytology of tumoral calcinosis: a case report","volume":"53","author":"Saleh","year":"2009","journal-title":"Acta Cytol"},{"key":"R20-12-20211004","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/RLU.0b013e31819a1ec5","article-title":"Intense F-18 FDG accumulation in idiopathic tumoral calcinosis","volume":"34","author":"Okuyama","year":"2009","journal-title":"Clin Nucl Med"},{"key":"R21-12-20211004","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1210\/jc.2009-0961","article-title":"Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis","volume":"94","author":"Bergwitz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-12-20211004","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ajmg.a.33337","article-title":"Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations","volume":"152A","author":"Ichikawa","year":"2010","journal-title":"Am J Med Genet"},{"key":"R23-12-20211004","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/en.2008-0877","article-title":"Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression","volume":"150","author":"Ichikawa","year":"2009","journal-title":"Endocrinology"},{"key":"R24-12-20211004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/17453670902807482","article-title":"Newly discovered mutations in the GALNT3 gene causing autosomal recessive hyperostosis\u2013hyperphosphatemia syndrome","volume":"80","author":"Gok","year":"2009","journal-title":"Acta Orthop"},{"key":"R25-12-20211004","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00198-008-0775-z","article-title":"A case of familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features","volume":"20","author":"Dumitrescu","year":"2009","journal-title":"Osteoporos Int"},{"key":"R26-12-20211004","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bone.2009.06.017","article-title":"Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia","volume":"45","author":"Shimizu","year":"2009","journal-title":"Bone"},{"key":"R27-12-20211004","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1210\/jc.2008-2396","article-title":"FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study","volume":"94","author":"Schouten","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-12-20211004","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ki.2009.414","article-title":"Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int"},{"key":"R29-12-20211004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ki.2009.464","article-title":"Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease","volume":"77","author":"Galitzer","year":"2010","journal-title":"Kidney Int"},{"key":"R30-12-20211004","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1681\/ASN.2009040427","article-title":"FGF23 fails to inhibit uremic parathyroid glands","volume":"21","author":"Canalejo","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R31-12-20211004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbrc.2010.06.110","article-title":"Establishment of sandwich ELISA for soluble alpha-Klotho measurement: age-dependent change of soluble alpha-Klotho levels in healthy subjects","volume":"398","author":"Yamazaki","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"R32-12-20211004","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00223-009-9270-6","article-title":"Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice","volume":"85","author":"Liang","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"R33-12-20211004","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"R34-12-20211004","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","article-title":"High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R35-12-20211004","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1359\/jbmr.090516","article-title":"Klotho variants and chronic hemodialysis mortality","volume":"24","author":"Friedman","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R36-12-20211004","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/ndt\/gfq089","article-title":"Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients","volume":"25","author":"Nasrallah","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R37-12-20211004","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"R38-12-20211004","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","article-title":"Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients","volume":"337","author":"Hsu","year":"2009","journal-title":"Am J Med Sci"},{"key":"R40-12-20211004","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"key":"R42-12-20211004","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R43-12-20211004","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/jc.2009-1671","article-title":"Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations","volume":"95","author":"Imel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R44-12-20211004","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2215\/CJN.03630509","article-title":"Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD","volume":"5","author":"Wetmore","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R45-12-20211004","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R46-12-20211004","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1517\/13543771003774100","article-title":"Therapeutic potential of Klotho\u2013FGF23 fusion polypeptides: WO2009095372","volume":"20","author":"Razzaque","year":"2010","journal-title":"Expert Opin Ther Pat"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01266029-201012000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:49:59Z","timestamp":1786042199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01266029-201012000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e32834041d4","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}